Tissue-engineered urethral stent graft, and preparation method and application thereof
A tissue engineering and graft technology, applied in biochemical equipment and methods, tissue regeneration, tissue culture, etc., can solve problems such as high incidence of complications, protracted and difficult recovery of autologous tissue repair, affecting the effect of surgery, urination and reproductive function, etc. , to achieve the effect of repairing urethral damage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] A method for preparing a tissue-engineered urethral stent graft.
[0041] Weigh 0.9g of the first polymer material (L-polylactic acid, molecular weight 30000Da), then weigh 0.1g of the second polymer material (collagen), place in a 15ml glass flask, add organic solvent (tetrahydrofuran) to 10ml , fully dissolved to obtain electrospinning solution.
[0042] Use a pipette to transfer the dissolved electrospinning liquid into the electrospinning syringe, connect the spinning nozzle (inner diameter 22G), set the high voltage to 15kV, the low pressure to -5kV, the flow rate to 3.0mL / h, and rotate the receiving device The distance from the nozzle is 12cm, and the receiving device is a cylindrical stainless steel tube with an outer diameter of 2.0cm and a length of 18cm. The rotational speed of the receiving device was adjusted to 900 rpm, and the tubular nanofibers were collected by electrospinning for 48 hours.
[0043] Harvest the successfully electrospun tubular nanofibe...
Embodiment 2
[0051] This embodiment provides a preparation method of a tissue-engineered urethral stent-graft, which is roughly the same as the preparation method provided in Example 1, except that the components of the tissue-engineered urethral stent-graft are different, and the differences are as follows:
[0052] The first polymer material used is polyglycolic acid (molecular weight 30000Da); the second polymer material is gelatin, and the organic solvent is chloroform.
Embodiment 3
[0054] This embodiment provides a preparation method of a tissue-engineered urethral stent-graft, which is roughly the same as the preparation method provided in Example 1, except that the components of the tissue-engineered urethral stent-graft are different and the preparation method is different.
[0055] The components differ as follows:
[0056] The first polymer material used is polycaprolactone (molecular weight 30000Da); the second polymer material is gelatin, and the organic solvent is dichloromethane.
[0057] The difference in preparation method is as follows:
[0058] Smooth muscle cells were isolated from kidney tissue in children, and after in vitro culture, renal smooth muscle cells were seeded on tubular nanofiber scaffolds.
PUM
Property | Measurement | Unit |
---|---|---|
length | aaaaa | aaaaa |
thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com